Guidelines

What is the survival rate for squamous cell carcinoma of the tongue?

What is the survival rate for squamous cell carcinoma of the tongue?

Prognosis for Oral Squamous Cell Carcinoma If carcinoma of the tongue is localized (no lymph node involvement), 5-year survival is > 75%. For localized carcinoma of the floor of the mouth, 5-year survival is 75%.

What is squamous cell carcinoma tongue?

The most common type of tongue cancer is squamous cell carcinoma (SCC). Squamous cells are the flat, skin like cells that cover the lining of the mouth, nose, larynx, thyroid and throat. Squamous cell carcinoma is the name for a cancer that starts in these cells.

Is oral squamous cell carcinoma aggressive?

The five-year survival rate of those newly diagnosed with oral cancer has not significantly improved over the last 50 years. OSCC is an aggressive tumor with low response to chemotherapy and basic resistance to most standard-of-care anticancer drugs.

What is the prognosis for cancer of the tongue?

Tongue cancer prognosis varies according to several factors, including age of the patient, treatment given, and stage of the cancer. The average five-year survival rate is about 42 percent.

What is the treatment for tongue cancer?

The main treatments for tongue cancer are surgery, radiotherapy and chemotherapy, either combined or on their own.

What is the tongue cancer survival rate?

If it has spread to a different part of the body, the stage is regional or distant. The earlier tongue cancer is caught, the better chance a person has of surviving five years after being diagnosed. For tongue cancer, 29.4% are diagnosed at the local stage. The 5-year relative survival for localized tongue cancer is 82.1%.

What are the different types of tongue cancer?

Types of tongue cancer. The most common type of tongue cancer is squamous cell carcinoma (SCC). Squamous cells are the flat, skin like cells that cover the lining of the mouth, nose, larynx, thyroid and throat. Squamous cell carcinoma is the name for a cancer that starts in these cells.